JP2023502259A5 - - Google Patents
Info
- Publication number
- JP2023502259A5 JP2023502259A5 JP2022529298A JP2022529298A JP2023502259A5 JP 2023502259 A5 JP2023502259 A5 JP 2023502259A5 JP 2022529298 A JP2022529298 A JP 2022529298A JP 2022529298 A JP2022529298 A JP 2022529298A JP 2023502259 A5 JP2023502259 A5 JP 2023502259A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- alveolar
- emphysema
- document
- respiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962940302P | 2019-11-26 | 2019-11-26 | |
| US62/940,302 | 2019-11-26 | ||
| US202063009134P | 2020-04-13 | 2020-04-13 | |
| US63/009,134 | 2020-04-13 | ||
| PCT/US2020/061774 WO2021108302A1 (en) | 2019-11-26 | 2020-11-23 | Cela-1 inhibition for treatment of lung disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023502259A JP2023502259A (ja) | 2023-01-23 |
| JP2023502259A5 true JP2023502259A5 (enExample) | 2023-10-24 |
Family
ID=76129647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529298A Pending JP2023502259A (ja) | 2019-11-26 | 2020-11-23 | 肺疾患の治療のためのｃｅｌａ－１阻害 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230002510A1 (enExample) |
| EP (1) | EP4065167A4 (enExample) |
| JP (1) | JP2023502259A (enExample) |
| AU (1) | AU2020394374A1 (enExample) |
| IL (1) | IL293238A (enExample) |
| WO (1) | WO2021108302A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1646160A (zh) * | 2002-03-13 | 2005-07-27 | 拜奥根Idec马萨诸塞公司 | 抗αvβ6抗体 |
| US8501449B2 (en) * | 2007-12-04 | 2013-08-06 | Proteon Therapeutics, Inc. | Recombinant elastase proteins and methods of manufacturing and use thereof |
| GB0916576D0 (en) * | 2009-09-22 | 2009-10-28 | Malmsten Nils M | Polypeptides and uses thereof |
| CN107690429B (zh) * | 2015-04-07 | 2022-02-25 | Ela制药有限公司 | 用于治疗和/或预防细胞或组织坏死的组合物，其特异性靶向组织蛋白酶c和/或cela1和/或cela3a和/或与其结构相关的酶 |
| EP3737666A4 (en) * | 2018-01-12 | 2022-01-05 | Kymera Therapeutics, Inc. | PROTEIN DEGRADATION AGENTS AND ASSOCIATED USES |
-
2020
- 2020-11-23 EP EP20894493.4A patent/EP4065167A4/en active Pending
- 2020-11-23 JP JP2022529298A patent/JP2023502259A/ja active Pending
- 2020-11-23 IL IL293238A patent/IL293238A/en unknown
- 2020-11-23 WO PCT/US2020/061774 patent/WO2021108302A1/en not_active Ceased
- 2020-11-23 AU AU2020394374A patent/AU2020394374A1/en active Pending
- 2020-11-23 US US17/778,188 patent/US20230002510A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007109118A3 (en) | RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS | |
| JP2016500111A5 (enExample) | ||
| JP2012500091A5 (enExample) | ||
| NZ592839A (en) | Treatment of diseases, disorders or conditions of the lung using placental cells | |
| NO20072920L (no) | Kombinasjon av metylxantinforbindelser og steroider for a behandle kroniske respirasjonssykdommer | |
| TWI406664B (zh) | 硫氧還蛋白（ｔｈｉｏｒｅｄｏｘｉｎ）產生促進劑 | |
| UA83813C2 (ru) | Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола | |
| AU2007334144A2 (en) | Method and device for improving efficiency of breathing | |
| WO2020217116A3 (en) | Long acting inhalation compositions of indacaterol | |
| WO2005086915A3 (en) | Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor | |
| BR112022014114A2 (pt) | Composições para gerenciar doença pulmonar obstrutiva crônica | |
| JP2020516689A5 (enExample) | ||
| JP2023512489A5 (enExample) | ||
| Giurgiu et al. | Comprehensive review of clinical presentation, treatment, and prognostic factors of airway burns | |
| WO2006083322A3 (en) | Methods for the treatment and prevention of infection using anti-selectin agents | |
| Wetsch et al. | Emergency extracorporeal membrane oxygenation to treat massive aspiration during anaesthesia induction. A case report | |
| MXPA04007294A (es) | Composicion para inhalacion. | |
| Echternach et al. | Does isolated expiratory vocal cord dysfunction exist? | |
| Lu et al. | Prophylactic systemic antibiotic and systemic glucocorticoid therapy after burn inhalation injury: a report of two cases and review of literature | |
| Yerosimou et al. | Hypercapnic Chronic Obstructive Pulmonary Disorder | |
| Dhar et al. | Awake prone positioning in COVID-19 pneumonia in India: A useful strategy in resource limited setting | |
| Peck | Respiratory burn injuries: An overview | |
| Papoff et al. | Bronchoscopic lung lavage and exogenous surfactant successfully reverse respiratory failure after severe chlorine exposure: A pediatric case report | |
| Vinsonneau et al. | Timing of initiation of renal replacement therapy in critically ill patients with acute kidney injury | |
| Alharbi | Study the effects of cigarette smoke on gingival epithelial cell growth and the expression of keratins |